Condition

Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)

ClinicalTrials.gov condition label

Clinical trials9

Recruiting0

Common interventions18

Lead sponsors shown5

Clinical trials

9 shown

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNCT01558778 · 2012-05-01

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadNCT01159067 · 2010-07-01

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNCT00890747 · 2009-08-01

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantNCT00795769 · 2008-08-08

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantNCT00408681 · 2006-06-01

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerNCT00060372 · 2003-04-01

Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerNCT00039091 · 2002-03-01

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerNCT00112593 · 1999-11-01

Common interventions

laboratory biomarker analysisOTHER4 deferasiroxDRUG2 management of therapy complicationsPROCEDURE2 cyclosporineDRUG1 enzyme-linked immunosorbent assayOTHER1 fludarabine phosphateDRUG1 ipilimumabBIOLOGICAL1 ipilimumabDRUG1 lithium carbonateDRUG1 musculoskeletal complications management/preventionPROCEDURE1 mycophenolate mofetilDRUG1 ondansetronDRUG1 peripheral blood stem cell transplantationPROCEDURE1 pharmacological studyOTHER1 sunitinib malateDRUG1 survey administrationOTHER1 therapeutic allogeneic lymphocytesDRUG1 total-body irradiationRADIATION1

Leading sponsors

Fred Hutchinson Cancer Center3 National Cancer Institute (NCI)3 City of Hope Medical Center1 Roswell Park Cancer Institute1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED6

TERMINATED2

WITHDRAWN1

Phase mix

NA3

PHASE13

PHASE23

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.